PMID: 6261139Apr 2, 1981Paper

Similarity of teleocidin B and phorbol ester tumour promoters in effects on membrane receptors

K UmezawaT Sugimura


The tumour promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and structurally related phorbol esters effect changes in avian and mammalian cell cultures that mimic transformation by oncogenic viruses or chemical carcinogens and the inhibition or induction of various types of differentiation (for review see refs 1--3). Unlike initiating carcinogens, which seem to act by binding covalently to cellular DNA, the primary site of action of the phorbol ester tumour promoters seems to be the cell membrane; indeed, specific high-affinity saturable receptors for phorbol esters have been identified in cell membranes. The recently discovered class of tumour promoters, the teleocidins, are as potent as TPA in the induction of ornithine decarboxylase in mouse skin, the inhibition of differentiation of Friend erythroleukaemia cells, the induction of HL-60 cell adhesion and the promotion of tumours on mouse skin. As the teleocidins are structurally unrelated to the phorbol esters, we set out to determine their effects on cell membranes and receptors. We found that in rodent cell cultures, teleocidin B and dihydroteleocidin B have effects similar to those of TPA and that, at nanomolar concentrations, teleocidin inhibits the binding of phorbo...Continue Reading


Aug 13, 1979·Biochemical and Biophysical Research Communications·H YamasakiI B Weinstein
Oct 12, 1979·Biochemical and Biophysical Research Communications·H FujikiT Sugimura
Feb 28, 1979·Biochemical and Biophysical Research Communications·K D BrownE Rozengurt
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·L S Lee, I B Weinstein
Apr 1, 1978·British Journal of Haematology·M M Roberts, M F Greaves
Jun 1, 1979·Journal of Cellular Physiology·L S Lee, I B Weinstein
Nov 21, 1977·Biochemical and Biophysical Research Communications·L Levine, A Hassid
Jan 1, 1974·CRC Critical Reviews in Toxicology·R K Boutwell
Apr 1, 1980·Cell·K B DelclosP M Blumberg

❮ Previous
Next ❯


Jan 1, 1984·Journal of Cancer Research and Clinical Oncology·H FujikiT Sugimura
Oct 1, 1986·Pflügers Archiv : European journal of physiology·C G CaratschF Eusebi
Nov 30, 1983·Biochemical and Biophysical Research Communications·S YamamotoR Kato
Apr 15, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·M KurobeK Hayashi
Jan 1, 1990·International Journal of Immunopharmacology·J FaveroJ W Parker
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·H FujikiR E Moore
Feb 23, 2011·Organic & Biomolecular Chemistry·Zhengren XuYanxing Jia
Sep 30, 1981·Biochemical and Biophysical Research Communications·S KumeT Oda
Aug 15, 1989·Biochemical and Biophysical Research Communications·J Heikkilä, K E Akerman
Feb 26, 1982·Biochemical and Biophysical Research Communications·M Collins, E Rozengurt
Mar 15, 1982·Biochemical and Biophysical Research Communications·K UmezawaT Takeuchi
Nov 1, 1992·Cytokine·M A DaytonD Benjamin
Jan 1, 1989·Japanese Journal of Cancer Research : Gann·K UmezawaT Takeuchi
Jan 1, 1983·Annals of the New York Academy of Sciences·P M BlumbergE Yeh
Jan 1, 1984·Journal of Cellular Physiology. Supplement·I B WeinsteinA Jeffrey
Jul 1, 1984·Journal of Cellular Physiology·A NovogrodskyK H Stenzel
Jan 1, 1981·Journal of Supramolecular Structure and Cellular Biochemistry·I B Weinstein
Jul 31, 1985·Biochemical and Biophysical Research Communications·N IsakovA Altman
May 20, 2017·Pharmaceuticals·Marta RuiSimona Collina
Apr 1, 1983·Environmental Health Perspectives·H FujikiR E Moore
Oct 15, 1985·International Journal of Cancer. Journal International Du Cancer·A BalanaT Tursz
Jan 15, 1982·International Journal of Cancer. Journal International Du Cancer·D DeliaG Goldstein
Apr 15, 1983·International Journal of Cancer. Journal International Du Cancer·H HoshinoH Fujiki
Aug 15, 1981·International Journal of Cancer. Journal International Du Cancer·H YamamotoT Sugimura
Feb 15, 2011·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Maciej PowerskiIngo Marzi
Dec 15, 1982·International Journal of Cancer. Journal International Du Cancer·M PatarroyoG Klein

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.